Exogenous interferon administration, such as interferon lambda via infusion, reduced hospitalizations by 50% in a Phase 3 trial for COVID-19.

“so you're getting around take exogenous interferon oh yeah absolutely you take it as a pill uh it's an infusion you would digest it in the stomach so this this was an infusion that they gave to patients uh I'm surprised that I haven't heard of like peptide Clinic selling into feron um can you can you inject interfer on sub subcutaneously uh you can in this this was actually published in the New England Journal of Medicine um it was uh interfer on Lambda I believe and it was a it was a uh phase three's trial looking at getting FDA approval I think probably because of the fact that um we weren't having as many hospitalized patients that probably hasn't gone through but in that study it reduced hospitalizations by 50%”